Literature DB >> 23391081

Direct percutaneous puncture embolization of type II endoleaks using a coaxial technique.

Yoshiaki Katada1, Shunichi Kondo, Shoichi Takahashi, Yohei Okita, Akihito Kagoshima, Kyu Rokkaku, Miwako Nozaki.   

Abstract

PURPOSE: To demonstrate a coaxial needle technique for direct percutaneous puncture embolization of type II endoleaks. TECHNIQUE: The technique is demonstrated in a 79-year-old woman and an 80-year-old man who developed type II endoleaks after endovascular repair of thoracic and internal iliac artery aneurysms, respectively. Expansion of the aneurysms required additional therapy. Fluoroscopy and cone-beam computed tomography-guided direct percutaneous endoleak sac embolization with n-butyl-2-cyanoacrylate (NBCA)-lipiodol was performed using the coaxial technique, which resulted in complete embolization of the endoleak sac. At 6 and 3 months after embolotherapy, respectively, the NBCA-lipiodol filled the endoleak sacs and the communicating channels up to the respective feeding arteries; no enlargement of the aneurysms was observed.
CONCLUSION: Direct percutaneous sac embolization using a coaxial technique for type II endoleaks is a feasible treatment and yields good short-term results. More experience with this technique and longer follow-up of these patients is needed.

Entities:  

Mesh:

Year:  2013        PMID: 23391081     DOI: 10.1583/12-4065.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  2 in total

1.  Type IA endoleak embolization after TEVAR via direct transthoracic puncture.

Authors:  Yoshiaki Katada; Shunichi Kondo; Eitoshi Tsuboi; Ken Nakamura; Kyu Rokkaku; Yoshihito Irie
Journal:  Jpn J Radiol       Date:  2015-01-28       Impact factor: 2.374

2.  Thoracic type Ia endoleak: direct percutaneous coil embolization of the aortic arch at the blood entry site after TEVAR and double-chimney stent-grafts.

Authors:  Christopher Bangard; Mareike Franke; Roman Pfister; Antje-Christin Deppe; Vladimir Matoussevitch; David Maintz; De-Hua Chang
Journal:  Eur Radiol       Date:  2014-03-19       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.